Oramed Pharmaceuticals
ORMP
#9146
Rank
C$0.24 B
Marketcap
C$5.58
Share price
5.12%
Change (1 day)
70.08%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2026 (TTM): C$6.06

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C$6.18. In 2025 the company made an earnings per share (EPS) of C$2.19 an increase over its 2024 EPS that were of C-$0.69.

EPS history for Oramed Pharmaceuticals from 2005 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$6.06176.71%
2025C$2.19-418.75%
2024C-$0.69-442.86%
2023C$0.20-114.89%
2022C-$1.3420.51%
2021C-$1.1239.29%
2020C-$0.80-31.71%
2019C-$1.17-4.65%
2018C-$1.238.86%
2017C-$1.13-9.2%
2016C-$1.2429.85%
2015C-$0.968.06%
2014C-$0.895.08%
2013C-$0.843.51%
2012C-$0.82137.5%
2011C-$0.34-60%
2010C-$0.86-0%
2009C-$0.86-16.67%
2008C-$1.03-25%
2007C-$1.37700%
2006C-$0.17303.56%
2005C-$0.04254

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
C$5.64-8.66%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
C$2.83-54.15%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
C-$7.42-220.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
C-$0.20-103.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
C$0.54-91.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel